INDV
Indivior Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$33.87
+4.38%Forward multiples
Based on analyst estimates
- P/E forward
- 7.14x
- P/E 2026E
- 7.97x
- P/E 2027E
- 7.28x
- P/E 2028E
- 6.95x
- P/S forward
- 2.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- 11.93x
- PEG TTM
- 0.18x
- Price / book
- -19.22x
- Price / sales
- 3.00x
- Price / cash flow
- -99.94x
Enterprise value
- Enterprise value
- $4.3B
- EV / sales
- 3.22x
- EV / EBITDA
- 9.80x
- EV / EBIT
- 8.27x
- Market cap
- $4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026